4 sectors expected to reignite CEE M&A under “new normal” conditions

Regional dealmakers remain cautious about the prospects of an M&A recovery in Central and Eastern Europe (CEE). Nonetheless, in spite of fears surrounding a second wave of the pandemic, activity is reigniting in selected sectors, albeit under "new normal" conditions.

Global M&A falls 52% in 2020

At the half-year stage, US dealflow was down sharply whilst China was least impacted. Megadeals declined although mid-market showed resiliency. Meanwhile, private equity's global M&A market share reached record level.

Dealcast: Covid-19 and healthcare M&A

No sector is closer than healthcare to the front-lines of the covid-19 pandemic.

Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A.

In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.